As far as I can tell the company is still in a similar shape as it was for the first half of the year when it was trading in the $6-7 rnage. It's lost 50% of it's value. Drug pipeline is still there, no major changes, any thoughts?
Submitted December 08, 2016 at 01:47PM by oarabbus http://ift.tt/2h1bMKv
No comments:
Post a Comment